481 related articles for article (PubMed ID: 19854606)
21. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
23. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Nakanishi Y
Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
Tajima Y; Nakanishi Y; Ochiai A; Tachimori Y; Kato H; Watanabe H; Yamaguchi H; Yoshimura K; Kusano M; Shimoda T
Cancer; 2000 Mar; 88(6):1285-93. PubMed ID: 10717608
[TBL] [Abstract][Full Text] [Related]
25. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
[TBL] [Abstract][Full Text] [Related]
26. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
27. [Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].
FENG J; MAO T; CHEN WH; FANG WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):715-8. PubMed ID: 21948541
[TBL] [Abstract][Full Text] [Related]
28. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
[TBL] [Abstract][Full Text] [Related]
29. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis].
An FS; Huang JQ; Chen SH
Ai Zheng; 2003 Sep; 22(9):974-7. PubMed ID: 12969532
[TBL] [Abstract][Full Text] [Related]
31. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
32. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
33. Is it time for a new TNM classification in esophageal carcinoma?
Bogoevski D; Onken F; Koenig A; Kaifi JT; Schurr P; Sauter G; Izbicki JR; Yekebas EF
Ann Surg; 2008 Apr; 247(4):633-41. PubMed ID: 18362626
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
[TBL] [Abstract][Full Text] [Related]
35. [Clinical study of lymph node metastatic pattern of thoracic esophageal squamous carcinoma].
Xie YT; Wang SQ; Zuo Q; Huang JQ; An FS; Chen SH; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):573-4. PubMed ID: 15897141
[TBL] [Abstract][Full Text] [Related]
36. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
37. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
[TBL] [Abstract][Full Text] [Related]
38. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]